Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 21, 2026; 32(15): 116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Published online Apr 21, 2026. doi: 10.3748/wjg.v32.i15.116083
Table 4 Clinical outcomes, mean ± SD/n (%)
| Variable | Non-CAP (n = 139) | CAP-assisted (n = 67) | P value |
| ICU admission (yes) | 37 (27.8) | 19 (31.1) | 0.635 |
| Mortality (yes) | 16 (12.0) | 7 (11.5) | 0.912 |
| Bleeding in 2nd scope (yes, if rescoped) | 12 (46.2) | 6 (42.9) | 0.842 |
| Hospital stay (days) | 5.30 ± 5.56 | 5.00 ± 2.54 | 0.606 |
| Post-admission transfusion (yes) | 45 (33.8) | 9 (14.8) | 0.006 |
| Transfusion amount (units) | 0.91 ± 1.31 | 0.44 ± 1.13 | 0.012 |
- Citation: Küçükdemirci Ö, Ayyildiz T, Bas B, Eruzun H, Efe N, Bektas A. Endoscopic transparent cap assisted hemostasis: A multicenter retrospective cohort study. World J Gastroenterol 2026; 32(15): 116083
- URL: https://www.wjgnet.com/1007-9327/full/v32/i15/116083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i15.116083